Related references
Note: Only part of the references are listed.Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity
Ahmed Younes et al.
TRANSLATIONAL ONCOLOGY (2021)
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy
Karin Lindberg et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Mechanisms of radiation-induced endothelium damage: Emerging models and technologies
Harshani Wijerathne et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
Sandra Demaria et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion
Yan Lan et al.
CANCER CELL (2021)
Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges
Lingling Zhu et al.
ONCOGENESIS (2021)
Additive Antiproliferative and Antiangiogenic Effects of Metformin and Pemetrexed in a Non-Small-Cell Lung Cancer Xenograft Model
Jiun-Long Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Guckenberger et al.
LANCET ONCOLOGY (2020)
Radiotherapy-immunotherapy combinations - perspectives and challenges
Michele Mondini et al.
MOLECULAR ONCOLOGY (2020)
Future Therapeutic Directions for Smac-Mimetics
Emma Morrish et al.
CELLS (2020)
Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy
Xiao-Yun Zhao et al.
CELLS (2020)
The oncogenic potential of a mutant TP53 gene explored in two spontaneous lung cancer mice models
Julian Ramelow et al.
BMC CANCER (2020)
Differential therapeutic effects of PARP and ATR inhibition combined with radiotherapy in the treatment of subcutaneous versus orthotopic lung tumour models
Vanessa Tran Chau et al.
BRITISH JOURNAL OF CANCER (2020)
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier cancer research network LUN 14-179
Greg A. Durm et al.
CANCER (2020)
Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening
Zhichao Li et al.
ISCIENCE (2020)
Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hype
Isabella Fornacon-Wood et al.
LUNG CANCER (2020)
Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models
Kyle Nolan et al.
CANCER CELL INTERNATIONAL (2020)
Organoid Models of Tumor Immunology
Kanako Yuki et al.
TRENDS IN IMMUNOLOGY (2020)
Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC
James W. Welsh et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy
Dawei Chen et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer
Mark F. McLaughlin et al.
PLOS ONE (2020)
Estimation of clinical trial success rates and related parameters
Chi Heem Wong et al.
BIOSTATISTICS (2019)
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
Daniel R. Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Radiosensitivity Differences between EGFR Mutant and Wild-Type Lung Cancer Cells are Larger at Lower Doses
Mai Anakura et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Serine Protease from Nereis virens Inhibits H1299 Lung Cancer Cell Proliferation via the PI3K/AKT/mTOR Pathway
Yanan Chen et al.
MARINE DRUGS (2019)
SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer
Zhen Tao et al.
CLINICAL CANCER RESEARCH (2019)
Long-term expanding human airway organoids for disease modeling
Norman Sachs et al.
EMBO JOURNAL (2019)
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Norman Sachs et al.
CELL (2018)
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
Roger Sun et al.
LANCET ONCOLOGY (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models
Sze-Kwan Lam et al.
ONCOLOGY REPORTS (2018)
A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening
Helen H. N. Yang et al.
CELL STEM CELL (2018)
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Silvia C. Formenti et al.
NATURE MEDICINE (2018)
Combined Immune Checkpoint Blockade and Radiation Therapy: Timing and Dose Fractionation Associated with Greatest Survival Duration Among Over 750 Treated Patients
R. Samstein et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
Narek Shaverdian et al.
LANCET ONCOLOGY (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Organs at risk in lung SBRT
F. De Rose et al.
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
miR-300 regulates cellular radiosensitivity through targeting p53 and apaf1 in human lung cancer cells
Jinpeng He et al.
CELL CYCLE (2017)
Radiobiology of stereotactic body radiation therapy (SBRT)
Miquel Macia i Garau
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2017)
Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages
Liwei Sun et al.
CELLULAR IMMUNOLOGY (2017)
Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management
Giuseppe Curigliano et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2
Danielle F. Eytan et al.
CANCER RESEARCH (2016)
Real-time Tumor Oxygenation Changes After Single High-dose Radiation Therapy in Orthotopic and Subcutaneous Lung Cancer in Mice: Clinical Implication for Stereotactic Ablative Radiation Therapy Schedule Optimization
Changhoon Song et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Pathology and biology of radiation-induced cardiac disease
Soile Tapio
JOURNAL OF RADIATION RESEARCH (2016)
Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with Ultracentral Non-Small Cell Lung Cancer
Hilal Tekatli et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer
Eduardo Guerrero et al.
LUNG CANCER (2016)
Clinical development of new drug-radiotherapy combinations
Ricky A. Sharma et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Understanding the Pathophysiology and Challenges of Development of Medical Countermeasures for Radiation-Induced Vascular/Endothelial Cell Injuries: Report of a NIAID Workshop, August 20, 2015
Merriline M. Satyamitra et al.
RADIATION RESEARCH (2016)
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
Kristina H. Young et al.
PLOS ONE (2016)
Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer
Grit S. Herter-Sprie et al.
JCI INSIGHT (2016)
Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts
John W. Cassidy et al.
CANCER RESEARCH (2015)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
Joe Y. Chang et al.
LANCET ONCOLOGY (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Hypoxia and Predicting Radiation Response
Richard P. Hill et al.
SEMINARS IN RADIATION ONCOLOGY (2015)
Modeling Disease In Vivo With CRISPR/Cas9
Lukas E. Dow
TRENDS IN MOLECULAR MEDICINE (2015)
The EGFR mutation status affects the relative biological effectiveness of carbon-ion beams in non-small cell lung carcinoma cells
Napapat Amornwichet et al.
SCIENTIFIC REPORTS (2015)
Complications from Stereotactic Body Radiotherapy for Lung Cancer
Kylie H. Kang et al.
CANCERS (2015)
Orthotopic Lung Cancer Murine Model by Nonoperative Transbronchial Approach
Takahiro Nakajima et al.
ANNALS OF THORACIC SURGERY (2014)
Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
Simon J. Dovedi et al.
CANCER RESEARCH (2014)
Stereotactic Ablative Radiation Therapy for Centrally Located Early Stage or Isolated Parenchymal Recurrences of Non-Small Cell Lung Cancer: How to Fly in a No Fly Zone
Joe Y. Chang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Preclinical Models for Translational Research Should Maintain Pace With Modern Clinical Practice
Joshua T. Dilworth et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Tissues in Different Anatomical Sites Can Sculpt and Vary the Tumor Microenvironment to Affect Responses to Therapy
Christel Devaud et al.
MOLECULAR THERAPY (2014)
Clinical development success rates for investigational drugs
Michael Hay et al.
NATURE BIOTECHNOLOGY (2014)
The oligometastatic state-separating truth from wishful thinking
David A. Palma et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Adam S. Crystal et al.
SCIENCE (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway
Jin Meng et al.
ONCOTARGET (2014)
In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells
Drazen B. Zimonjic et al.
BMC CANCER (2013)
Spheroid Culture of Primary Lung Cancer Cells with Neuregulin 1/HER3 Pathway Activation
Hiroko Endo et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century
Samuel A. Williams et al.
LABORATORY INVESTIGATION (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Stereotactic body radiotherapy for multisite extracranial oligometastases Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease
Joseph K. Salama et al.
CANCER (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
Elizabeth S. Nakasone et al.
CANCER CELL (2012)
Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis
Osamu Takahashi et al.
CLINICAL CANCER RESEARCH (2012)
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy
Steven Eric Finkelstein et al.
IMMUNOTHERAPY (2012)
COMBINATION OF EXTERNAL BEAM RADIOTHERAPY (EBRT) WITH INTRATUMORAL INJECTION OF DENDRITIC CELLS AS NEO-ADJUVANT TREATMENT OF HIGH-RISK SOFT TISSUE SARCOMA PATIENTS
Steven E. Finkelstein et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects
Maria Grazia Ruocco et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Radical Treatment of Non-Small-Cell Lung Cancer Patients with Synchronous Oligometastases Long-Term Results of a Prospective Phase II Trial (Nct01282450)
Dirk De Ruysscher et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer
Michael D. Hasselle et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Patient-derived tumour xenografts as models for oncology drug development
John J. Tentler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Radiation-Induced Vascular Damage in Tumors: Implications of Vascular Damage in Ablative Hypofractionated Radiotherapy (SBRT and SRS)
Heon Joo Park et al.
RADIATION RESEARCH (2012)
Bioluminescent Orthotopic Mouse Models of Human Localized Non-Small Cell Lung Cancer: Feasibility and Identification of Circulating Tumour Cells
Pierre Mordant et al.
PLOS ONE (2011)
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control
Michelle A. Stinauer et al.
RADIATION ONCOLOGY (2011)
Location, Location, Location-Makes All the Difference for Hypoxia in Lung Tumors
Amit Maity et al.
CLINICAL CANCER RESEARCH (2010)
Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics
Edward E. Graves et al.
CLINICAL CANCER RESEARCH (2010)
ACCUMULATION OF DNA DOUBLE-STRAND BREAKS IN NORMAL TISSUES AFTER FRACTIONATED IRRADIATION
Claudia E. Ruebe et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
Robert Timmerman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy
Michael T. Milano et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
Vincent C. Daniel et al.
CANCER RESEARCH (2009)
Grape Seed Proanthocyanidins Inhibit the Growth of Human Non-Small Cell Lung Cancer Xenografts by Targeting Insulin-Like Growth Factor Binding Protein-3, Tumor Cell Proliferation, and Angiogenic Factors (Publication with Expression of Concern. See vol. 24, pg. 6101, 2018)
Suhail Akhtar et al.
CLINICAL CANCER RESEARCH (2009)
Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer
Frank J. Lagerwaard et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: A systematic review and pooled analysis
Tawee Tanvetyanon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
Ralph R. Weichselbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells
Keith A. Cengel et al.
NEOPLASIA (2007)
Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor
Philipp Steiner et al.
CLINICAL CANCER RESEARCH (2007)
Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma
Christopher A. Carter et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer
Robert Timmerman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
James L. Tatum et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2006)
Phase II study on stereotactic body radiotherapy of colorectal metastases
Morten Hoyer et al.
ACTA ONCOLOGICA (2006)
Contributions of human tumor xenografts to anticancer drug development
EA Sausville et al.
CANCER RESEARCH (2006)
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
F Ishikawa et al.
BLOOD (2005)
Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century
MR Capecchi
NATURE REVIEWS GENETICS (2005)
Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts:: In vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy
H Wang et al.
CLINICAL CANCER RESEARCH (2004)
Comparison of established cell lines at different passages by karyotype and comparative genomic hybridization
SL Wenger et al.
BIOSCIENCE REPORTS (2004)
Liver metastases from breast cancer: Long-term survival after curative resection
M Selzner et al.
SURGERY (2000)
Share Paper
